What is Alamar Biosciences, Inc.'s contact information?

Alamar Biosciences, Inc.'s contact information: 1 (510) 626-9888, +15106269888.

How many employees does Alamar Biosciences, Inc. have?

Alamar Biosciences, Inc. has 200 employees.

What industry does Alamar Biosciences, Inc. belong to?

Alamar Biosciences, Inc. is in the industry of: Research, Biotechnology, Healthcare.

What are Alamar Biosciences, Inc.'s official social media profiles?

Alamar Biosciences, Inc. Linkedin Page Alamar Biosciences, Inc. Twitter Page

What tech stack does Alamar Biosciences, Inc. use?

Some of the popular technologies that Alamar Biosciences, Inc. uses are: Linkedin Ads, Google Analytics, Linkedin Insight Tag, WordPress.

What are Alamar Biosciences, Inc.'s office addresses?

Alamar Biosciences, Inc. has 3 known office addresses: 47071 Bayside Pkwy, Fremont, CA 94538, United States 47071 Bayside Pkwy, Fremont, California, 94538, US 47071 Bayside Pkwy, Fremont, California 94538, Us.

What is Alamar Biosciences, Inc.'s estimated annual revenue?

Alamar Biosciences, Inc.'s revenue is $2,500,000

What is Alamar Biosciences, Inc.'s open headcount?

Alamar Biosciences, Inc. has 7 job postings.

What is the number of ad campaigns for Alamar Biosciences, Inc.?

Alamar Biosciences, Inc. has no advertisements yet.

What is the number of recent news articles about Alamar Biosciences, Inc.?

Alamar Biosciences, Inc. has 77 news articles.

Alamar Biosciences, Inc. - Pubrio Company Profile & Intent

Alamar Biosciences, Inc.

United States · Research

Research

Biotechnology

Healthcare

Alamar Biosciences, Inc. is a life sciences company based in Fremont, California, founded in 2018. The company focuses on advancing proteomics to enable early disease detection through innovative technologies. Led by Dr. Yuling Luo, known for creating the RNAscope technology, Alamar aims to enhance precision in proteomics research. The company has developed a highly sensitive proteomics platform that can profile thousands of proteins from just one microliter of plasma. Its proprietary NULISA Platform, combined with the ARGO HT System, offers exceptional detection sensitivity. Alamar also runs a Certified Service Provider Program, partnering with labs like ESYA Labs, Frontage Labs, and Sapient to support researchers in biomarker research and assay development. In February 2024, Alamar Biosciences secured $128 million in a Series C financing round to further its commercialization efforts, highlighting its growth potential in the field of precision proteomics.